Revenue ($USD) : $2,279,997,000
R&D spend : $92,984,000.00
Employees : 14,500
Fiscal year end : 12/31/22
CEO : Vivek Jain
Syringe and infusion technology company ICU Medical is climbing up the Big 100 ranks following its $2.35 billion acquisition of Smiths Medical last year.
With Smiths Medical’s offerings including syringe and ambulatory infusion devices, vascular access, and vital care products, the merger created an infusion therapy company with estimated annual revenues of roughly $2.5 billion.
The company could grow even more with rumors swirling earlier this year that it was one of the contenders for some of the business units that Medtronic wants to divest. –SW